A Systematic Review of Treatments for Hidradenitis Suppurativa | Dermatology | JAMA Dermatology | JAMA Network
[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.234.207.100. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Study
Apr 2012

A Systematic Review of Treatments for Hidradenitis Suppurativa

Author Affiliations

Author Affiliations: Follicular Disorders Clinic, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.

Arch Dermatol. 2012;148(4):439-446. doi:10.1001/archdermatol.2011.1950
Abstract

Objectives To conduct a systematic review of the effectiveness of various modalities to treat hidradenitis suppurativa (HS) and to establish recommendations on its appropriate management.

Data Sources MEDLINE, Cochrane, and PubMed databases.

Study Selection English-language prospective, retrospective, and case studies describing at least 4 patients with HS.

Data Extraction Data quality and validity were addressed by multiple reviewers using independent extraction.

Data Synthesis Studies were categorized as treatments using antibiotics, biological agents, laser surgery, excisional surgery, or miscellaneous modalities. Of 62 publications included in the review, 4 studies met criteria to be assigned the highest grade for quality of evidence.

Conclusions Shown to be effective treatments for HS were a clindamycin-rifampin combination regimen, a course of infliximab, monthly Nd:YAG laser sessions, and surgical excision and primary closure with a gentamicin sulfate–collagen sponge. Most therapies used to treat HS were supported by limited or weak scientific evidence. A treatment approach is presented based on the evidence and on clinical experience at the Follicular Disorders Clinic, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan. This review emphasizes the need for large randomized controlled trials to evaluate treatment options for HS.

×